The role of stage specific inflammation/immunomodulation in the evolution of myelodysplastic syndrome from low-to-high risk and impact on therapeutic approaches

Project: Research

StatusFinished
Effective start/end date17/09/1516/09/18

Funding

  • Victorian Cancer Agency: AUD800,000.00